Galectin Therapeutics Inc (GALT)
3.23
+0.09
(+2.87%)
USD |
NASDAQ |
May 17, 16:00
3.235
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics 1 Year Total Returns (Daily): 93.83% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | 93.83% |
May 15, 2024 | 86.59% |
May 14, 2024 | 68.05% |
May 13, 2024 | 82.25% |
May 10, 2024 | 67.40% |
May 09, 2024 | 83.62% |
May 08, 2024 | 72.34% |
May 07, 2024 | 94.77% |
May 06, 2024 | 101.7% |
May 03, 2024 | 98.81% |
May 02, 2024 | 103.0% |
May 01, 2024 | 104.7% |
April 30, 2024 | 99.43% |
April 29, 2024 | 104.5% |
April 26, 2024 | 96.02% |
April 25, 2024 | 100.0% |
April 24, 2024 | 78.80% |
April 23, 2024 | 76.04% |
April 22, 2024 | 59.38% |
April 19, 2024 | 65.20% |
April 18, 2024 | 70.71% |
April 17, 2024 | 66.50% |
April 16, 2024 | 69.15% |
April 15, 2024 | 94.53% |
April 12, 2024 | 94.61% |
Date | Value |
---|---|
April 11, 2024 | 105.9% |
April 10, 2024 | 89.11% |
April 09, 2024 | 89.42% |
April 08, 2024 | 79.81% |
April 05, 2024 | 85.57% |
April 04, 2024 | 53.06% |
April 03, 2024 | 46.91% |
April 02, 2024 | 19.52% |
April 01, 2024 | 16.19% |
March 28, 2024 | 20.10% |
March 27, 2024 | 23.59% |
March 26, 2024 | 20.92% |
March 25, 2024 | 18.88% |
March 22, 2024 | 23.86% |
March 21, 2024 | 22.61% |
March 20, 2024 | 10.55% |
March 19, 2024 | 7.14% |
March 18, 2024 | 9.18% |
March 15, 2024 | 8.42% |
March 14, 2024 | 3.12% |
March 13, 2024 | 8.79% |
March 12, 2024 | 5.35% |
March 11, 2024 | 7.49% |
March 08, 2024 | -0.97% |
March 07, 2024 | -2.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.17%
Minimum
May 18 2022
153.7%
Maximum
Apr 28 2021
-10.06%
Average
-17.26%
Median
1 Year Total Returns (Daily) Benchmarks
Madrigal Pharmaceuticals Inc | -25.68% |
Viking Therapeutics Inc | 180.2% |
89bio Inc | -49.24% |
Terns Pharmaceuticals Inc | -42.83% |
Enanta Pharmaceuticals Inc | -47.00% |